Buy Cipla with a target of Rs 565 -- Sarvendra Srivastava

Sarvendra Srivastava of Phisense.com has a buy call on Cipla Ltd. with a target price of Rs 565.0 .The current market price of Cipla Ltd. is Rs 550.25 Time period given by analyst is Intra Day when Cipla Ltd. price can reach defined target. Sarvendra Srivastava recommended to keep stoploss at Rs 546.6 .

Cipla Ltd., incorporated in the year 1935, is a largecap company with a market cap of ₹ 44135.42 crore operating in Pharmaceuticals and health care sector.

Cipla Ltd. key Products/Revenue Segments include Tablets & Capsules which contributed ₹ 7497.86 Cr to Sales Value (61.52 % of Total Sales), Injections/Sterile Solution which contributed ₹ 1339.00 Cr to Sales Value (10.98 % of Total Sales), Aerosols which contributed ₹ 1104.45 Cr to Sales Value (9.06 % of Total Sales), Bulk Drugs which contributed ₹ 1089.04 Cr to Sales Value (8.93 % of Total Sales), Liquids which contributed ₹ 448.08 Cr to Sales Value (3.67 % of Total Sales), Creams which contributed ₹ 279.84 Cr to Sales Value (2.29 % of Total Sales), Export Incentives which contributed ₹ 150.16 Cr to Sales Value (1.23 % of Total Sales), Others which contributed ₹ 129.08 Cr to Sales Value (1.05 % of Total Sales), Other Operating Revenue which contributed ₹ 66.51 Cr to Sales Value (0.54 % of Total Sales), Other Services which contributed ₹ 44.72 Cr to Sales Value (0.36 % of Total Sales) and Scrap which contributed ₹ 37.49 Cr to Sales Value (0.30 % of Total Sales)for the year ending 31-Mar-2016.

For the quarter ended 31-12-2016, the company has reported a Consolidated sales of ₹ 3550.02 Cr., down -3.32% from last quarter Sales of ₹ 3671.88 Cr. and up 15.64% from last year same quarter Sales of ₹ 3069.89 Cr. Company has reported net profit after tax of ₹ 385.80 Cr. in latest quarter. The company’s CEO is Mr.Y K Hamied. It's Board of Directors include Mr.Kedar Upadhye, Mr.Mital Sanghvi, Mr.Umang Vohra, Dr.Peter Mugyenyi, Mr.Adil Zainulbhai, Mr.Ashok Sinha, Mr.M K Hamied, Mr.Peter Lankau, Mr.S Radhakrishnan, Mr.Umang Vohra, Mr.Y K Hamied, Mrs.Samina Vaziralli, Ms.Ireena Vittal, Ms.Naina Lal Kidwai, Ms.Punita Lal, Mr.Mital Sanghvi. Company has its registered office at Mumbai Central, Mumbai, 400008, Maharashtra. Company has V Sankar Aiyar & Co. as its auditors. As on 31-03-2017, the company has a total of 788,432,729 shares outstanding.